Dr. Francisco Lopez-Munoz, MD, PhD, DLitt, studied Medicine at Complutense University, Madrid (1988). He received his PhD Degree in Medicine at Complutense University in 1993, with a Thesis that won the Doctorate Extraordinary Award, and another PhD Degree in Spanish Language and Literature at University of Alcala in 2015. Currently he is Professor of Pharmacology, Director of International Doctorate School, Chairman of the Research Ethics Committee, and Assistant Director of Academic Staff at Camilo Jose Cela University, and Research Fellow at "Hospital 12 de Octubre" Research Institute (Madrid, Spain), and Portucalense Institute of Neuropsychology and Cognitive and Behavioral Neurosciences (INPP), Universidade Portucalense Infante Dom Henrique (Porto, Portugal). He is specialist in Pharmaceutical Medicine, worked in the pharmaceutical industry as Medical Director. He has supervised 10 PhD theses, has participated in 26 research projects, and acts as evaluator of research projects and degrees for several European Agencies (ANECA – Spain, EUFISCDI – Romania, HRB – Ireland). Dr. Lopez-Munoz is editor/author of 25 books, highlighting its History of Psychopharmacology (4 volumes; NPP Books, 2014), Neurobiology of Depression (Taylor&Francis, 2012), and Melatonin, Neuroprotective Agents and Antidepressant Therapy (Springer International, 2016), and 209 chapters of books related to the psychopharmacology. He has published 141 papers on indexed journals and 190 in Spanish and Latin American journals, and he has a H-index = 27. He has served on the Organising Committee of 18 Congresses in the area of pharmacology and psychiatry, and he has given 28 conferences and 150 communications in scientific meetings. Dr. Lopez-Munoz is member of several scientific societies (including CINP) and editorial boards, and has participated, as visiting Professor in different Spanish and international academic centres. Dr. Lopez-Munoz has various awards for his research career, and he is Academician of the Royal Academy of Doctors and Correspondent Academician of the Royal Academy of Medicine and Surgery of Cadiz.

Neuropsychopharmacology; Neurosciences; Biological bases of drug abuse and dual diagnosis; Psychotropic drugs interactions; Neurobiology of metal disorders; Bibliometric techniques applied to mental health-related disciplines and neuropsychopharmacology; Combination therapies with antidepressant drugs in resistant depression and with antipsychotics drugs in patients with refractory schizophrenia; and the history of the psychopharmacology and neurosciences.